رجوع
نطاق اليوم
KWD 438.42
KWD 449.14
نطاق 52 أسبوعًا
KWD 265.00
KWD 615.00
حجم التداول
197,756
متوسط 50 يوم / 200 يوم
KWD 468.57
/
KWD 437.29
الإغلاق السابق
KWD 447.72
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -35.4 | 0.3 |
| P/B | 16.9 | 2.9 |
| ROE % | -42.5 | 3.7 |
| Net Margin % | -30.1 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 705.670
+58.6%
Low: KWD 527.000
High: KWD 964.000
ربحية السهم المستقبلية
-KWD 4.488
الإيرادات المقدّرة
1.5 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 70.330
KWD 59.581 – KWD 79.312
|
4.9 B | 4 |
| FY2029 |
KWD 49.530
KWD 41.959 – KWD 55.855
|
3.9 B | 4 |
| FY2028 |
KWD 31.371
KWD 16.070 – KWD 49.150
|
3 B | 11 |
النقاط الرئيسية
Negative free cash flow of -190.02M
Capital efficient — spends only 0.05% of revenue on capex
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)432.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-42.49%
ROIC-23.52%
Net Margin-30.08%
Op. Margin-31.31%
الأمان
Debt / Equity
0.59
Current Ratio4.01
Interest Coverage-13.45
التقييم
P/E Ratio
-35.41
P/B Ratio16.94
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 432.05% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 958.40M | Net Income (TTM) | -288.28M |
| ROE | -42.49% | ROA | -22.89% |
| Gross Margin | 94.14% | Operating Margin | -31.31% |
| Net Margin | -30.08% | Free Cash Flow (TTM) | -190.02M |
| ROIC | -23.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 4.01 |
| Interest Coverage | -13.45 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -35.41 | P/B Ratio | 16.94 |
| P/S Ratio | 10.65 | PEG Ratio | 1.10 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 10.21B | Enterprise Value | 10.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 958.40M | 180.13M | 0.0 | 0.0 | 0.0 |
| Net Income | -288.28M | -465.89M | -373.63M | -295.35M | -241.85M |
| EPS (Diluted) | -12.85 | -21.90 | -19.99 | -17.23 | -14.63 |
| Gross Profit | 902.26M | 173.90M | 0.0 | 0.0 | 0.0 |
| Operating Income | -300.10M | -497.88M | -380.50M | -293.57M | -242.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.26B | 1.04B | 640.55M | 362.57M | 273.33M |
| Total Liabilities | 656.90M | 287.86M | 235.21M | 165.18M | 77.23M |
| Shareholders' Equity | 602.69M | 754.38M | 405.33M | 197.39M | 196.11M |
| Total Debt | 354.36M | 119.57M | 117.19M | 49.89M | 797,000.0 |
| Cash & Equivalents | 198.69M | 100.02M | 99.92M | 331.55M | 36.27M |
| Current Assets | 1.25B | 1.03B | 637.28M | 361.37M | 271.68M |
| Current Liabilities | 310.29M | 169.28M | 118.55M | 115.89M | 76.84M |